BNP Paribas Asset Management’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,589
Closed -$210K 971
2018
Q3
$210K Buy
+4,589
New +$206K ﹤0.01% 908
2018
Q2
Sell
-57,029
Closed -$2.19M 976
2018
Q1
$2.19M Buy
57,029
+31,675
+125% +$1.18M 0.02% 619
2017
Q4
$876K Buy
25,354
+19,499
+333% +$682K 0.01% 748
2017
Q3
$263K Buy
5,855
+1,576
+37% +$84K ﹤0.01% 886
2017
Q2
$268K Sell
4,279
-975
-19% -$56.2K ﹤0.01% 901
2017
Q1
$322K Sell
5,254
-163,130
-97% -$10.9M ﹤0.01% 907
2016
Q4
$10.7M Buy
168,384
+162,592
+2,807% +$10.6M 0.1% 271
2016
Q3
$386K Buy
5,792
+1,079
+23% +$74.3K ﹤0.01% 1002
2016
Q2
$358K Sell
4,713
-303
-6% -$21.5K ﹤0.01% 1010
2016
Q1
$306K Hold
5,016
﹤0.01% 1010
2015
Q4
$390K Buy
5,016
+2,708
+117% +$234K ﹤0.01% 979
2015
Q3
$254K Hold
2,308
﹤0.01% 968
2015
Q2
$273K Buy
+2,308
New +$262K ﹤0.01% 996

Other funds holding EVHC

BNP Paribas Asset Management's EVHC Position: Q4 2018 in Review

BNP Paribas Asset Management sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 4,589 shares — an estimated $210K sold.

BNP Paribas Asset Management first reported a position in EVHC in Q2 2015 and held it in 13 quarters. The position peaked at $10.7M in Q4 2016. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • BNP Paribas Asset Management reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • BNP Paribas Asset Management sold 4,589 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $210K.
  • BNP Paribas Asset Management first reported a position in Envision Healthcare Holdings Inc in Q2 2015 and held it in 13 quarters.
  • BNP Paribas Asset Management's Envision Healthcare Holdings Inc position peaked at $10.7M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on BNP Paribas Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.